John Knorr, PharmD, BCTXP
banner
johnpk.bsky.social
John Knorr, PharmD, BCTXP
@johnpk.bsky.social
Transplant PharmD | PGY1 RPD
Philadelphia, PA
I wish these addressed risk from conventional immunosuppression used in transplant (Thymo, calcineurin inhibitors TAC/CSA, antimetabolites MMF/AZA). Particularly in kidney transplant, we occasionally see HBVr in HBcAb+/sAg-, despite HBsAb+, but the practice of universal proph is not widely adopted.
January 31, 2025 at 12:58 PM
We've started using it!
December 17, 2024 at 1:08 AM
Candidates for LOIs. Then letter writers when a formal letter is required.
December 14, 2024 at 1:34 PM
LiverTox is a great reference to use here to evaluate patterns and timing of injury.
November 22, 2024 at 9:41 PM
Discussed this recently at a formulary meeting. Based on a few studies ~17-20% of pts on TIW HD experience K >6.0. Those against adding due to high cost claimed it would encourage nonadherence to dietary restrictions... Or would it enable healthier dietary choices by alleviating restrictions??
November 20, 2024 at 2:57 AM
Has one of the best brand names and icons too. Trojan horse.
November 17, 2024 at 2:26 PM
The medsky labeler is my favorite one.
November 17, 2024 at 2:21 PM
I will be giving two talks, one is an update on MASLD and is one on the impact of race in clinical calculations. I will also be at the residency showcase.
November 17, 2024 at 2:16 PM
Please add me :)
November 14, 2024 at 9:49 PM
Surgery too.
How about keeping Mg >/= 2.0 for the general population?
November 14, 2024 at 11:49 AM